For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Not what the doctor ordered
Wednesday 28 May 2025, 05:30 AM

Cutting red tape around advertising of unapproved medicines to boost tourism revenue smacks of a team-building exercise [Image: DrAfter123 on iStock]
When regulation, health and tourism ministers teamed up, the result was a surprising prescription: more medical advertising to drive visitor spending. Side effects may include raised eyebrows, writes Barbara Fountain
A regulation minister, a health minister and a tourism minister walked into a bar. You might have heard this story before, I wrote about it. But it is
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.